Dasatinib
- Strength
- 80 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Teva Pharmaceuticals, Inc.
dasatinib
Listed by E.R. Squibb & Sons, L.L.C.
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0003-0855 |
| FDA application | NDA021986 |
| RxNorm concept | 643105 |
| Package sizes listed | 1 |
| Marketed since | October 2010 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Teva Pharmaceuticals, Inc.
Dr.Reddys Laboratories Inc
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited
Aurobindo Pharma Limited
Apotex Corp.
Apotex Corp.
Prasco Laboratories
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.